tumour cell heterogeneity maintained cooperating subclones wnt-driven mammary cancers 
cancer genome sequencing studies indicate single breast cancer typically harbours multiple genetically distinct subclones1- carcinogenesis involves breakdown cell-cell cooperation normally maintains epithelial tissue architecture individual subclones within malignant microenvironment commonly depicted self-interested competitors56 alternatively breast cancer subclones might interact cooperatively gain selective growth advantage cases although interclonal cooperation shown drive tumorigenesis fruitfly models78 definitive evidence functional cooperation epithelial tumour cell subclones mammals lacking use mouse models breast cancer show interclonal cooperation can essential tumour maintenance aberrant expression secreted signalling molecule wnt1 generates mixed-lineage mammary tumours composed basal luminal tumour cell subtypes purportedly derive bipotent malignant progenitor cell residing atop tumour cell hierarchy9 using somatic hras mutations clonal markers show wnt tumours indeed conform hierarchical configuration others unexpectedly harbour genetically distinct basal hras mutant luminal hras wild-type subclones subclones required efficient tumour propagation strictly depends luminally produced wnt1 biclonal tumours challenged wnt withdrawal simulate targeted therapy analysis tumour regression relapse revealed basal subclones recruit heterologous wnt-producing cells restore tumour growth alternatively absence substitute wnt source original subclones often evolve rescue wnt pathway activation drive relapse either restoring cooperation switching defector strategy uncovering similar modes interclonal cooperation human cancers may inform efforts aimed eradicating tumour cell communities 
